Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) has become a major therapeutic problem worldwide. Combination therapy may be an alternative chemotherapeutic option.

Source: Diagnostic Microbiology and Infectious Disease - February 3, 2018 Category: Microbiology Authors: Yun Cai, Deqing Yang, Jin Wang, Rui Wang Source Type: research